Fermata Advisors’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-49,997
| Closed | -$390K | – | 251 |
|
|
2025
Q1 | $390K | Buy |
49,997
+3,000
| +6% | +$23.4K | 0.07% | 190 |
|
|
2024
Q4 | $219K | Buy |
46,997
+4,267
| +10% | +$19.9K | 0.04% | 243 |
|
|
2024
Q3 | $230K | Buy |
42,730
+8,590
| +25% | +$46.3K | 0.05% | 220 |
|
|
2024
Q2 | $301K | Buy |
34,140
+2,689
| +9% | +$23.7K | 0.07% | 162 |
|
|
2024
Q1 | $370K | Buy |
31,451
+2,025
| +7% | +$23.8K | 0.08% | 134 |
|
|
2023
Q4 | $331K | Sell |
29,426
-27,276
| -48% | -$307K | 0.08% | 123 |
|
|
2023
Q3 | $384K | Buy |
+56,702
| New | +$384K | 0.11% | 109 |
|
|
2023
Q1 | – | Sell |
-24,611
| Closed | -$156K | – | 116 |
|
|
2022
Q4 | $156K | Buy |
24,611
+300
| +1% | +$1.9K | 0.05% | 134 |
|
|
2022
Q3 | $151K | Buy |
24,311
+300
| +1% | +$1.86K | 0.05% | 129 |
|
|
2022
Q2 | $212K | Buy |
24,011
+4,425
| +23% | +$39.1K | 0.07% | 148 |
|
|
2022
Q1 | $165K | Buy |
19,586
+1,631
| +9% | +$13.7K | 0.06% | 181 |
|
|
2021
Q4 | $183K | Buy |
17,955
+5,125
| +40% | +$52.2K | 0.07% | 184 |
|
|
2021
Q3 | $249K | Buy |
12,830
+1,080
| +9% | +$21K | 0.11% | 146 |
|
|
2021
Q2 | $206K | Buy |
+11,750
| New | +$206K | 0.12% | 150 |
|